Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,546 | 29,439 | 11,136 | 16,187 | 27,370 |
| Marketable Securities | 130,650 | 129,060 | 109,634 | 118,252 | 116,765 |
| Receivables | N/A | 8,000 | N/A | N/A | N/A |
| TOTAL | $161,038 | $172,379 | $124,604 | $139,094 | $149,304 |
| Non-Current Assets | |||||
| PPE Net | 11,069 | 11,333 | 11,872 | 12,175 | 12,643 |
| Intangibles | 23,675 | 23,730 | 24,308 | 22,294 | 0 |
| Other Non-Current Assets | 12,607 | 12,778 | 12,942 | 13,129 | 13,283 |
| TOTAL | $47,351 | $47,841 | $49,122 | $47,598 | $25,926 |
| Total Assets | $208,389 | $220,220 | $173,726 | $186,692 | $175,230 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,470 | 2,293 | 3,896 | 3,310 | 1,305 |
| Accrued Expenses | 10,089 | 10,828 | 12,971 | 16,629 | 7,393 |
| Other current liabilities | N/A | N/A | N/A | 7,189 | N/A |
| TOTAL | $16,897 | $14,141 | $25,759 | $28,332 | $9,225 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 7,660 | N/A | N/A |
| Other Non-Current Liabilities | 19,534 | 19,759 | 20,099 | 20,414 | 20,730 |
| TOTAL | $21,698 | $21,923 | $22,263 | $20,414 | $20,730 |
| Total Liabilities | $38,595 | $36,064 | $48,022 | $48,746 | $29,955 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,942 | 58,888 | 58,133 | 44,323 | 39,527 |
| Common Shares | 59 | 59 | 45 | 44 | 39 |
| Retained earnings | -306,782 | -289,481 | -286,225 | -270,628 | -247,579 |
| Other shareholders' equity | -102 | -60 | 63 | -105 | -85 |
| TOTAL | $169,794 | $184,156 | $125,704 | $137,946 | $145,275 |
| Total Liabilities And Equity | $208,389 | $220,220 | $173,726 | $186,692 | $175,230 |